NxGen Brands Inc. (NXGB)
OTCMKTS · Delayed Price · Currency is USD
0.0015
0.00 (0.00%)
At close: Dec 26, 2025
NxGen Brands Market Cap
NxGen Brands has a market cap or net worth of $501.87 thousand as of December 26, 2025. Its market cap has decreased by -52.78% in one year.
Market Cap
501.87K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since April 5, 2016, NxGen Brands's market cap has increased from 180.03K to 501.87K, an increase of 178.76%. That is a compound annual growth rate of 11.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 501.87K | 706,757.75% |
| Dec 23, 2024 | 71.00 | -99.98% |
| Dec 29, 2023 | 397.40K | -34.99% |
| Dec 29, 2022 | 611.31K | -83.01% |
| Dec 31, 2021 | 3.60M | 74.41% |
| Dec 31, 2020 | 2.06M | 111.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 724.00M |
| Elite Pharmaceuticals | 520.52M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 376.54M |
| CytoDyn | 359.24M |
| Nika Pharmaceuticals | 291.10M |
| Silence Therapeutics | 290.02M |